SUBSCRIBE
SUBSCRIBE
News   Policy

MedWatch: Update of Safety Review for Vytorin, Zetia, and Zocor

January 9, 2009 | 
1 min read
The FDA has completed its review of the final clinical study report of ENHANCE and issued an update. Read the MedWatch safety summary, including links to the January 2008 FDA Early Communication and the January 2009 Update.
Regulatory
Merck & Co.
MORE ON THIS TOPIC
Human kidney made out of lines. Medical Concept. 3D Rendering.
Kidney disease
Roche-Ionis’ RNA therapy reduces kidney disease marker, opening path to swift FDA nod
September 23, 2026
 · 
2 min read
 · 
Annalee Armstrong
FDA
Novo’s turnaround plan, weight loss wins, Ultragenyx’s Sanfilippo approval, IPO blitz
September 23, 2026
 · 
2 min read
 · 
Jef Akst
Illustration showing businessman trying to create his own road
FDA
Compass vows to press on with FDA application despite new trial request
September 22, 2026
 · 
3 min read
 · 
Annalee Armstrong
FDA
FDA hears input on psychedelics, PDUFA, lung cancer’s next-gen therapies boost survival
September 16, 2026
 · 
1 min read
 · 
Jef Akst